Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer

YASUHIRO OYAMA, SHINJIRO NAGAO, LIN NA, KOSUKE YANAI, MASAYO UMEBAYASHI, KATSUYA NAKAMURA, SHUNTARO NAGAI, AKIKO FUJIMURA, AKIO YAMASAKI, KAZUNORI NAKAYAMA, TAKASHI MORISAKI and HIDEYA ONISHI
Anticancer Research August 2021, 41 (8) 4047-4052; DOI: https://doi.org/10.21873/anticanres.15205
YASUHIRO OYAMA
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINJIRO NAGAO
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIN NA
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOSUKE YANAI
2Departments of Surgery and Oncologys, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAYO UMEBAYASHI
3Fukuoka General Cancer Clinic, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUYA NAKAMURA
2Departments of Surgery and Oncologys, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUNTARO NAGAI
2Departments of Surgery and Oncologys, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIKO FUJIMURA
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
4Departments of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIO YAMASAKI
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUNORI NAKAYAMA
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI MORISAKI
3Fukuoka General Cancer Clinic, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEYA ONISHI
1Departments of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ohnishi@surg1.med.kyushu-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 41 (8)
Anticancer Research
Vol. 41, Issue 8
August 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer
YASUHIRO OYAMA, SHINJIRO NAGAO, LIN NA, KOSUKE YANAI, MASAYO UMEBAYASHI, KATSUYA NAKAMURA, SHUNTARO NAGAI, AKIKO FUJIMURA, AKIO YAMASAKI, KAZUNORI NAKAYAMA, TAKASHI MORISAKI, HIDEYA ONISHI
Anticancer Research Aug 2021, 41 (8) 4047-4052; DOI: 10.21873/anticanres.15205

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer
YASUHIRO OYAMA, SHINJIRO NAGAO, LIN NA, KOSUKE YANAI, MASAYO UMEBAYASHI, KATSUYA NAKAMURA, SHUNTARO NAGAI, AKIKO FUJIMURA, AKIO YAMASAKI, KAZUNORI NAKAYAMA, TAKASHI MORISAKI, HIDEYA ONISHI
Anticancer Research Aug 2021, 41 (8) 4047-4052; DOI: 10.21873/anticanres.15205
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer
  • Murine Double Minute 2 Antagonist Nutlin-3 Enhanced Chemosensitivity in Esophageal Squamous Cell Carcinoma
  • Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant Melanoma
Show more Experimental Studies

Similar Articles

Keywords

  • TrkB
  • BDNF
  • pancreatic cancer
  • proliferation
  • invasion
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire